SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

FDA Approves Generic Lutathera for Adults With GEP-NETs

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Body-Related TikTok Reels Tied to Self-Objectification, Mood

Viewing appearance-focused TikTok videos is associated with increased self-objectification in women, as well as changes in mood.

Could Psilocybin Prevent Nerve Damage From Chemotherapy?

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

Report Backs Proactive Pediatric-Adult Diabetes Care Handoff

International consensus from three societies recommends planning the transition for youth with diabetes at least 1-2 years in advance.

Waist Size, Not Just BMI, Predicts Mortality in Older Adults

Adults aged 65 years or older with a higher waist circumference face a notably higher risk for all-cause mortality even at a normal BMI, according to a 14-year US cohort study.

FDA Okays Finerenone for CKD in Adults With Type 1 Diabetes

It is the first new treatment in more than 30 years approved for treating chronic kidney disease in T1D.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Latest News

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Viewing appearance-focused TikTok videos is associated with increased self-objectification in women, as well as changes in mood.

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

International consensus from three societies recommends planning the transition for youth with diabetes at least 1-2 years in advance.

Adults aged 65 years or older with a higher waist circumference face a notably higher risk for all-cause mortality even at a normal BMI, according to a 14-year US cohort study.

It is the first new treatment in more than 30 years approved for treating chronic kidney disease in T1D.

News All Time

Food Tracking for Weight Loss: More Tracking, More Loss

In a study of 5132 app users, higher food tracking frequency was associated with greater weight loss, with more than 70% losing at least 5% of their body weight at 6 months.

Dysesthesia Risk Appears to Rise With GLP-1s

A meta-analysis suggests that GLP-1 drugs may raise the risk for dysesthesia, with greater weight loss potentially linked to a higher risk.

Thyroid, Other Autoimmune Issues Tied to Fertility Decline

Women with thyroid autoimmunity plus other autoimmune conditions have a nearly 6% rate of premature ovarian insufficiency, which is fivefold higher than that of those without autoimmune disorders.

FDA Clears New Type of Insulin Patch Pump From Beta Bionics

The company anticipates its two pumps will work with a next-generation insulin dosing algorithm.

Endocrine Society Launches New Initiatives Around Obesity

A new scientific statement was published and Center on Obesity was launched simultaneously.

New Guidance Addresses Diabetes and Smoking Cessation

The issue is underemphasized in clinical diabetes care, authors say.

Retatrutide: It’s Already in Your Waiting Room

Social media has triggered a retatrutide tsunami. What can clinicians do when patients disclose taking an unapproved weight-loss drug?

Whole-Plant Extract Outperforms THC on Glycemia

Whole-plant cannabis extract beats THC alone at improving glucose control in obese mice. Here's what the science means for patient conversations.

Novo Nordisk Says Wegovy Approved in China for MASH

Denmark's Novo Nordisk ⁠said on Thursday its blockbuster ⁠weight-loss drug Wegovy had ⁠been approved ‌in China as the first GLP-1 RA class of drugs for the ‌treatment of MASH.

Diabetes Care in Danish Care Homes May Miss the Mark

About 1 in 8 Danish care home residents with T2D admitted from 2018 to 2023 used glucose-lowering drugs, and most continued treatment despite having A1c levels below recommended targets.

Weekly Basal Insulin + Semaglutide Combo May Benefit T2D

Novo Nordisk’s phase 3b trial shows once-weekly IcoSema improves glycemic control and weight with less hypoglycemia than insulin glargine U100 in adults with type 2 diabetes.

Menopausal Symptoms Worse in Women With Type 2 Diabetes

An observational study finds a higher number of symptoms and greater severity among midlife women with type 2 diabetes than among those without.

High Semaglutide Dropout Rates Signal Adherence Challenge

With nearly half of patients discontinuing semaglutide within 12 months — especially younger adults — clinicians face a growing challenge in sustaining long-term treatment.

Obesity Rises Faster in Young Adults, Steeper in Older Adults

Obesity is increasing faster among young adults worldwide, even as older adults still carry the greater overall burden, a new analysis of 196 countries over three decades finds.

Soccer-Spanish FA Launches Fertility Support Programme for Female Players and Referees

Spain's football federation has unveiled an agreement to support fertility treatment for female players and referees, presenting the measure as another way to give women in...

Midwifery Goes Beyond Birth: What Is Still Overlooked?

Midwives’ roles extend across reproductive, pregnancy, postpartum, pelvic floor, and community care, but cultural, structural, and professional barriers can limit their practice.

Recommended News For You

Emicizumab in Infants With Hemophilia A: Safe and Effective Use.

Rural-urban disparities seen in cervical cancer

Implant-based reconstruction linked to increased risk of breast lymphomas

Belzutifan Plus Pembro Approved for Adjuvant RCC

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Recommended Articles For You

Case-Based Learning on Functional Bone Marrow Recovery Following Sequential Immune Challenges 

Obesity as a major risk factor for cancer 

The Power of White Blood Cells: How They Help Keep Us Healthy 

Advanced Pathways in Oncology for Better Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Single-dose radiation before surgery can eradicate breast cancer

2.

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

3.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

4.

There has been a new target found that might stop blood cancer.

5.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

1.

Molecular Matching for Hematologic Therapy Selection

2.

Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies

3.

Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial

4.

Examining Serum Osmolality: What It Is And How To Test For It

5.

All You Need To Know About Melanoma Maligna: Causes, Symptoms & Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

5.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot